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causes for oedema including nephropathy, cardiac failure, hepatic
cirrhosis, and hypoalbuminemia due to any other cause, were
excluded by renal and liver function tests, thyroid profile, ECG and
baseline echocardiography. Varicose veins were ruled out by
clinical examination. Amlodipine therapy was substituted in all
the cases with an efficacy e equivalent dose of Cilnidipine (5mg of
Amlodipine ¼ 10 mg of Cilnidipine). Clinical assessment of ankle
oedema and measurement of bilateral ankle circumference, body
weight, blood pressure, and pulse rate were taken at the onset of
the study and after 4 weeks of Cilnidipine therapy.
Results: Out of 56 patients included in the study, 32 (57.1%) were
male. Mean age of patients were 58 ± 9.6 yrs and average duration
of Amlodipine therapy at the time of inclusion in the study was 12
± 3.5 months. 40 (71.4%) patients were receiving the 5mg of
Amlodipine daily. At completion of the study, oedema had
resolved in all the patients. There was a significant decreases in
bilateral ankle circumference and body weight (P<0.001). There
was no significant change in mean arterial blood pressure and
pulse rate.
Conclusions: Therapy with Cilnidipine resulted in complete res-
olution of Amlodipine induced oedema in all the cases without
significant worsening of hypertension or tachycardia. Cilnidipine
is an acceptable alternative antihypertensive drug for patients
with Amlodipine induced oedema.
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Objective: Recent evidence suggests close obesity and arterial
hypertension association. Both pathological states are character-
ized by low-grade inflammation which result in adipokines
dysfunction: increased activity of proinflammatory cytokines,
such as tumor necrosis factor e a (TNF-a), interleukin-6 (IL-6) and
decreased activity of anti-inflammatory cytokines e interleukin-
10 (IL-10).
The aim of our research was study relationships between serum
TNF-a and IL-10 concentrations and external breathing function
disorders in hypertensive patients with obesity.
Methods: 55 Patients with arterial hypertension (AH) were
examined. Serum TNF-a and IL-10 levels by ELISA were detected.
All patients underwent anthropometry and spirography. Patients
were divided into 3 group depend on body mass and FEV1 means:
1 gr. e hypertensives with normal body mass; 2nd gr. e obesity-
related hypertensives without bronchial obstruction (FEV1 >80%);
3rd gr. e obesity-related hypertensives with bronchial obstruction
(FEV1 <80%).
Results: Serum TNF-a (1st gr. e 3.32 ± 1.3 pg/ml, 2nd gr. 6.37 ± 0.6
pg/ml, 3rd gr. e 13.78 ± 4.1 pg/ml; p < 0.05 in all cases) levels
increasing were found in relation to obesity and bronchial
obstruction development. IL-10 serum levels decreased depend on
obesity progression to attainminimummeans in AH patients with
obesity and bronchial obstruction syndrome (1st gr. e 9.25 ± 1.8
pg/ml, 2nd gr. e 6.57 ± 0.5 pg/ml, 3rd gr. e 4.05 ± 0.9 pg/ml; p < 0.05
in all cases).
Conclusion: Obtained data demonstrate TNF-a levels elevation
and IL-10 levels reduction with maximum changes in obesity-
associated arterial hypertension with obstructive disorders of
external breathing function. Our results suggest possibility of
TNF-a and IL-10 involving to obstructive type of ventilation dis-
orders development in the patients with AH and obesity.
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Background: The potential use of assays of BNP for detection of
diastolic abnormalities associated with alterations in blood pres-
sure has not been elucidated.
Objective: This study was designed to determine whether
increased plasma concentrations of BNP sensitively reflect
abnormal diastolic function associated with hypertension.
Methods: We studied 60 patients with a primary diagnosis of
Hypertention. All patients were studied with the use of pulsed
Doppler transmitral flow velocity and color Tissue Doppler echo-
cardiography for the evaluation of left ventricular diastolic func-
tion. Serum BNP was determined with a sandwich immunoassay
on ‘Elecys 2010. Anova / Dunnet’s t test was used when comparing
means. The diagnostic utility of BNP was compared with the
echocardiographic probability of LV dysfunction through the use
of receiver-operating characteristic (ROC) curves.
Results: Patients were divided into 2 groups on the basis of
whether they manifested normal or abnormal LV diastolic func-
tion by echocardiography. Patients diagnosed with abnormal
diastolic function had a mean BNP concentration of 285±31 pg/
mL, whereas the normal subjects had a mean BNP concentration
of 31±4 pg/mL. The difference between groups was significant (P
<0.001). The AUC for the ROC curve with BNP used to detect any
abnormal diastolic dysfunction was 0.91 (95% CI, P <0.001). A BNP
value of 62 pg/mL had a sensitivity of 85%, a specificity of 83% for
detecting diastolic dysfunction.
Conclusion: Our results suggest that the plasma BNP level is
influenced by diastolic dysfunction and an assay for BNP can
reliably detect the presence of diastolic dysfunction.
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Objective: The purpose of this study was to understand the usage
pattern of antihypertensive drugs and their fixed dose combina-
tion in clinical practice.
Methods: Doctors were asked to fill a questionnaire based on their
clinical experiences in dealing with patients with hypertension.
These questions were to be answered based on the doctor’s clin-
ical experience. Descriptive statistics were used to describe the
results.
Results: We collected completely filled questionnaires from 427
doctors. 46.33 % doctors in their clinical practice encounter 20- 40
newly diagnosed hypertensive patients per month. Among all the
patients with newly diagnosed hypertensive there were about 10-
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